{"id":"azm-group","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-15%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL2108795","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Azithromycin binds to the 50S subunit of bacterial ribosomes, preventing the translocation of peptidyl-tRNA and thereby inhibiting protein synthesis. This action is bacteriostatic, meaning it prevents the growth and replication of bacteria, rather than killing them outright.","oneSentence":"Azithromycin targets bacterial ribosomes to inhibit protein synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:03:27.176Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute bacterial sinusitis"},{"name":"Acute otitis media"}]},"trialDetails":[{"nctId":"NCT05026749","phase":"PHASE3","title":"Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2022-02-27","conditions":"Respiratory Syncytial Virus Infections","enrollment":370},{"nctId":"NCT02543073","phase":"PHASE1, PHASE2","title":"MSC for Treatment of Interstitial Lung Disease After Allo-HSCT","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2014-09","conditions":"Lung Diseases, Interstitial, Hematopoietic Stem Cell Transplantation, Bronchiolitis Obliterans","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":28,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AZM Group","genericName":"AZM Group","companyName":"University of Alabama at Birmingham","companyId":"university-of-alabama-at-birmingham","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin targets bacterial ribosomes to inhibit protein synthesis. Used for Community-acquired pneumonia, Acute bacterial sinusitis, Acute otitis media.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}